NCT05690360

Brief Summary

We recently identify in our previous study 'NCT052115832' the progesterone levels for the embryo transfer in natural thaw cycles. Since it is shown that progesterone levels work better than LH levels in order to detect the time to transfer, we aimed to show the pregnancy outcomes of the natural thaw cycles which had the transfer date regarding the progesterone levels.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 15, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 10, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 19, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2023

Completed
Last Updated

January 19, 2023

Status Verified

January 1, 2023

Enrollment Period

5 months

First QC Date

January 10, 2023

Last Update Submit

January 10, 2023

Conditions

Infertility

Outcome Measures

Primary Outcomes (3)

  • Cummulative Live Birth Rate

    Live birth rates of Patient with NC-FET followed up with progesterone levels

    10 months

  • Biochemical pregnancy results

    Biochemical pregnancy results of patients with NC-FET followed up with progesterone levels

    2 months

  • Pregnancy complications

    Obstetric Complications of Patient with NC-FET followed up with progesterone levels

    10 months

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Participants are going to be selected from the patients who applied to infertility clinic, and are pregnant with in vitro fertilization natural cycle- frozen embryo transfer.

You may qualify if:

  • patients with regular menstrual cycle
  • patients aged btw 20-40
  • patients with pregnancy with NC-FET by using the progesterone for the detection of ovulation

You may not qualify if:

  • Spontenous pregnancies
  • Multiple pregnancies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Acibadem University Atakent Hospital

Istanbul, 34303, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • NAZLI ALBAYRAK, MD

    Acıbadem University School of Medicine

    PRINCIPAL INVESTIGATOR

  • TURGUT AYDIN, MD

    Acıbadem University School of Medicine

    PRINCIPAL INVESTIGATOR

  • NADIYE KOROGLU, MD

    Acıbadem University School of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Turgut Aydin, MD

CONTACT

00905323722713turgut.aydin@acibadem.com

Nazli Albayrak, MD

CONTACT

00905054111626albayraknazli@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident in training at Acibadem University, School of Medicine, Department of Obstetrics and Gynecology

Study Record Dates

First Submitted

January 10, 2023

First Posted

January 19, 2023

Study Start

November 15, 2022

Primary Completion

April 15, 2023

Study Completion

August 15, 2023

Last Updated

January 19, 2023

Record last verified: 2023-01

Locations

TU(1)